View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
FRIDAY, March 11 (HealthDay News) -- Patients with early rheumatoid arthritis taking anti-tumor necrosis factor (TNF) therapy without prior use of disease-modifying anti-rheumatic drugs (DMARD)/methotrexate do not have an increased risk of serious infections or malignancies, according to a meta-analysis published online Feb. 25 in Arthritis & Rheumatism.
Andrew E. Thompson, M.D., from the University of Western Ontario in London, Canada, and colleagues conducted a meta-analysis of six randomized, double-blind, placebo-controlled trials to determine the rates of serious infection and malignancy in patients with early rheumatoid arthritis who started anti-TNF therapy without prior DMARD/methotrexate use. A total of 2,183 patients receiving biologic therapy and 1,236 patients receiving methotrexate therapy were included. The risk of serious infection and malignancy was measured using a pooled odds ratio (OR).
The investigators found that there was a slightly higher, but not statistically significant, risk of serious infections requiring hospitalization (pooled OR, 1.16) and malignancies (pooled OR, 1.07) in patients receiving anti-TNF therapy compared to patients receiving methotrexate (controls).
"This meta-analysis has not shown an increased risk of malignancy or serious infections in newly diagnosed patients with rheumatoid arthritis treated with anti-TNF therapy. However, further review of this population of patients in an observational inception cohort would be important to confirm and strengthen these findings," the authors write.
Full Text (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top